Skip to main content
SpringerLink
Log in

Malignant Melanoma

  • Chapter
Pathology of Melanocytic Nevi and Malignant Melanoma

Abstract

The purpose of this chapter is to provide a highly practical approach to the histopathologic diagnosis of melanoma of the skin and its differential diagnosis. Emphasis is placed not only on the major forms of conventional melanoma but also on unusual and rare variants that are difficult to recognize. (1–342)

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 269.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Berwick M. Epidemiology: current trends, risk factors, and environmental concerns In: Balch CM, Houghton AN, Sober AJ, Soong S-J, eds. Cutaneous Melanoma. 3rd ed. St. Louis: Quality Medical, 1998: 551–1.

    Google Scholar 

  2. Berwick M. Why are people still dying of from melanoma? Arch Dermatol 1999; 135: 1534–6.

    Article  PubMed  CAS  Google Scholar 

  3. Lipsker DM, Hedelin G, Held E, et al. Striking increase of thin melanomas contrasts with stable incidence of thick melanomas. Arch Dermatol 1999; 135: 1451–6.

    Article  PubMed  CAS  Google Scholar 

  4. Roush GC, Schymura MJ, Holford TR. Risk for cutaneous melanoma in recent Connecticut birth cohorts. Am J Public Health 1985; 75: 679–82.

    Article  PubMed  CAS  Google Scholar 

  5. Roush GC, Holford TR, Schymura MJ, et al. Cancer risk and incidence trends: Connecticut Perspective. Washington DC: Hemisphere 1987.

    Google Scholar 

  6. Sondik EJ, Kessler LG, Ries LAG. Cancer statistics review, 1973–1987 [Publ. No. NIH 90–2789]. Washington, DC: U.S. Government Printing Office, 1990.

    Google Scholar 

  7. Miller RW, Young JL Jr, Novakovic B. Childhood cancer. Cancer 1995; 75 (Suppl 1): 395–405.

    Article  PubMed  CAS  Google Scholar 

  8. Goldstein AM, Tucker MA. Genetic epidemiology of cutaneous melanoma. A global perspective. Arch Dermatol 1999; 137: 1493–6.

    Google Scholar 

  9. Clark WH Jr. A classification of malignant melanoma in man correlated with histogenesis and biologic behavior. In: Montagna W, Hu F, eds. Advances in the Biology of the Skin. New York: Pergamon, 1967; 8: 621–47.

    Google Scholar 

  10. Clark WH Jr, From L, Bernardino EA, Mihm MC. The histogenesis and biologic behavior of primary human malignant melanomas of the skin. Cancer Res 1969; 29: 705–27.

    PubMed  Google Scholar 

  11. McGovern VJ, Mihm MC Jr, Bailly C, et al. The classification of malignant melanoma and its histologic reporting. Cancer 1973; 32: 1446–57.

    Article  PubMed  CAS  Google Scholar 

  12. Mishima Y. Melanocytic and nevocytic malignant melanoma. Cellular and subcellular differentiation. Cancer 1967; 20: 632–49.

    Article  PubMed  CAS  Google Scholar 

  13. Ten Seldam R, Helwig E, Sobin L, et al. Histological typing of skin tumours. In: Histological Typing of Skin Tumours. International Histological Classification of Tumors [No. 12]. Geneva: World Health Organization, 1974.

    Google Scholar 

  14. Mishima Y, Matsunaka J. Pagetoid premalignant melanosis and melanoma: differentiation from Hutchinson’s freckle. J Invest Derm 1975; 65: 434–40.

    Article  PubMed  CAS  Google Scholar 

  15. Price NM, Rywlin AM, Ackerman AB. Histologic criteria for the diagnosis of superficial spreading malignant melanoma: Formulated on the basis of proven metastatic lesions. Cancer 1976; 38: 2434–41.

    Article  PubMed  CAS  Google Scholar 

  16. Ackerman AB. Malignant melanoma: a unifying concept. Hum Pathol 1980; 11: 591–5.

    Article  PubMed  CAS  Google Scholar 

  17. Elder DE, Jucovy PM, Tuthill RJ, Clark WH Jr. The classification of malignant melanoma. Am J Dermatopathol 1980; 2: 315–20.

    Article  PubMed  CAS  Google Scholar 

  18. Heenan PJ, Holman CDJ. Nodular malignant melanoma: a distinct entity or a common end stage? Am J Dermatopathol 1982; 4: 477–8.

    Article  PubMed  CAS  Google Scholar 

  19. Vollmer R. Pathology of melanoma. In: Seigler H, ed. Clinical Management of Melanoma. The Hague: Nijhoff, 1982: 9–40.

    Chapter  Google Scholar 

  20. Holman CDJ, Armstrong B, Heenan P. A theory of the etiology and pathogenesis of human cutaneous malignant melanoma. J Natl Cancer Inst 1983; 71: 651–6.

    PubMed  CAS  Google Scholar 

  21. Reed RJ. The pathology of human cutaneous melanoma. In: Costanzi JJ, ed. Malignant Melanoma I. The Hague: Nijhoff, 1983; 85–116.

    Chapter  Google Scholar 

  22. Clark WH Jr, Elder DE, Van Horn M. The biologic forms of malignant melanoma. Human Pathol 1984; 17: 443–50.

    Article  Google Scholar 

  23. Clark WH Jr, Elder DE, Guerry D IV, et al. A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma. Hum Pathol 1984; 15: 1147–65.

    Article  PubMed  Google Scholar 

  24. Heenan PJ, Matz LR, Blackwell JB, et al. Inter-observer variation between pathologists in the classification of cutaneous malignant melanoma in western Australia. Histopathology 1984; 8: 717–29.

    Article  PubMed  CAS  Google Scholar 

  25. Holman CDJ, Armstrong BK. Cutaneous malignant melanoma and indicators of total accumulated exposure to the sun: An analysis separating histogenetic types. J Natl Cancer Inst 1984; 73: 75–82.

    CAS  Google Scholar 

  26. English DR, Heenan PJ, Holman CD, et al. Melanoma in Western Australia in 1980–81: incidence and characteristics of histological types. Pathology 1987; 19: 383–92.

    Article  PubMed  CAS  Google Scholar 

  27. Heenan PJ, Armstrong BK, English DE, et al. Pathological and epidemiological variants of cutaneous malignant melanoma. In: Elder DE, ed. Pathobiology of Malignant Melanoma. Basel: Karger, 1987: 107–46.

    Google Scholar 

  28. Herlyn M, Clark WH, Rodeck U, et al. Biology of tumor progression in human melanocytes. Lab Invest 1987; 56: 461–74.

    PubMed  CAS  Google Scholar 

  29. Clark WH Jr, Elder DE, Guerry D IV, et al. Model predicting survival in stage I melanoma based on tumor progression. J Natl Cancer Inst 1989; 81: 1893–904.

    Article  PubMed  Google Scholar 

  30. Clark WH. Tumor progression and the nature of cancer. Br J Cancer 1991; 64: 631–644.

    Article  PubMed  CAS  Google Scholar 

  31. Clark WH Jr, Evans HL, Everett MA, et al. Early melanoma: histologic terms. Am J Dermatopathol 1991; 13: 579–82.

    Article  PubMed  Google Scholar 

  32. Barnhill RL, Mihm MC, Jr. The histopathology of cutaneous malignant melanoma. Semin Diag Pathol 1993; 10: 47–75.

    CAS  Google Scholar 

  33. Barnhill RL. Pathology of Melanocytic Nevi and Malignant Melanoma. Boston: Butterworth-Heinemann, 1995.

    Google Scholar 

  34. Barnhill RL, Mihm MC Jr. Histopathology of malignant melanoma and its precursor lesions. In: Balch CM, Houghton AN, Sober AJ, Soong S-J, eds. Cutaneous Melanoma. 3rd ed. St. Louis: Quality Medical, 1998: 103–133.

    Google Scholar 

  35. Walter SD, King WD, Marrett LD. Association of cutaneous malignant melanoma with intermittent exposure to ultraviolet radiation: results of a case-control study in Ontario, Canada. Int J Epidemiol 1999; 28: 418–427.

    Article  PubMed  CAS  Google Scholar 

  36. Barnhill RL. Malignant melanoma, dysplastic melanocytic nevi, and Spitz tumors: histologic classification and characteristics. Clin Plast Surg 2000; 27: 331–60.

    PubMed  CAS  Google Scholar 

  37. Barnhill RL. The histological diagnosis of melanoma. Clin Lab Med Pathol2001; 20: 645–65.

    Google Scholar 

  38. Gruber SB, Barnhill RL, Stenn KS, Roush GC. Nevomelanocytic proliferations in association with cutaneous malignant melanoma: a multivariate analysis. J Am Acad Dermatol 1989; 21: 773–80.

    Article  PubMed  CAS  Google Scholar 

  39. Barnhill RL, Roush GC, Duray PH. Correlation of histologic architectural and cytoplastic features with nuclear atypia in atypical (dysplastic) nevomelanocytic nevi. Hum Pathol 1990; 21: 51–58.

    Article  PubMed  CAS  Google Scholar 

  40. Barnhill RL. Current status of the dysplastic melanocytic nevus. J Cutan Pathol 1991; 18: 147–59.

    Article  PubMed  CAS  Google Scholar 

  41. Dubow BE, Ackerman AB. Malignant melanoma in situ: the evolution of a concept. Mod Pathol 1990; 3: 734 44.

    Google Scholar 

  42. Cox NH, Aitchison TC, Sirel JM, Mackie RM. Comparison between lentigo maligna melanoma and other types of malignant melanoma of the head and neck. Brit J Cancer 1996; 73: 940–44.

    Article  PubMed  CAS  Google Scholar 

  43. Mihm MC Jr, Fitzpatrick TB, Brown MM, et al. Early de-tection of primary cutaneous malignant melanoma. A color atlas. N Engl J Med 1973; 289: 989–96.

    Article  PubMed  Google Scholar 

  44. Barnhill RL, Fitzpatrick TB, Fandrey K, et al. The Pigmented Lesion Clinic: A Color Atlas and Synopsis of Benign and Pigmented Lesions. New York: McGraw-Hill, 1995.

    Google Scholar 

  45. McGovern VJ. Spontaneous regression of melanoma. Pathology 1975; 7: 91–9.

    Article  PubMed  CAS  Google Scholar 

  46. Fallowfield ME, Cook MG. Pagetoid infiltration in primary cutaneous melanoma. Histopathology 1992; 20: 417–20.

    Article  PubMed  CAS  Google Scholar 

  47. Cotton DWK. Pagetoid infiltration in primary cutaneous melanoma. Histopathology 1993; 94.

    Google Scholar 

  48. Haupt HM, Stern JB. Pagetoid melanocytosis: histologic features in benign and malignant lesions. Am J Surg Pathol 1995; 19: 792–7.

    Article  PubMed  CAS  Google Scholar 

  49. Stern JB, Haupt HM. Pagetoid melanocytosis: tease or tocsin? Semin Diagn Pathol 1998; 15: 225–9.

    PubMed  CAS  Google Scholar 

  50. Megahed M, Schon M, Selimovic D, Schon MP. Reliability of diagnosis of melanoma in situ. Lancet 2002; 359: 1921–2.

    Article  PubMed  Google Scholar 

  51. Kamino H, Kiryu H, Ratech H. Small malignant melanomas: clinicopathologic correlation and DNA ploidy analysis. J Am Acad Dermatol 1990; 22: 1032–8.

    Article  PubMed  CAS  Google Scholar 

  52. Gonzalez A, West A, Pitha J, Taira J. Small-diameter invasive melanomas: clinical and pathologic characteristics. J Cutan Path 1996; 23: 126–32.

    Article  PubMed  CAS  Google Scholar 

  53. Barnhill RL, Barnhill MA, Berwick M, Mihm MC Jr. The histologic spectrum of pigmented spindle cell nevus: a review of 120 cases with emphasis on atypical variants. Hum Pathol 1991; 22: 52–8.

    Article  PubMed  CAS  Google Scholar 

  54. Busam KJ, Barnhill RL. Pagetoid Spitz nevus: intraepidermal Spitz tumor with prominent pagetoid spread. Am J Surg Pathol 1995; 19 (9): 1061–7.

    Article  PubMed  CAS  Google Scholar 

  55. Hutchinson, J. Notes on the cancerous process and on new growth in general. Arch Surg (London) 1892; 3: 315–22.

    Google Scholar 

  56. Hutchinson J. On tissue dotage. Arch Surg (London) 1892; 3: 315–22.

    Google Scholar 

  57. Hutchinson J. On cancer. Arch Surg (London) 1893; 4: 61–3.

    Google Scholar 

  58. Hutchinson J. Lentigo-melanosis: a further report. Arch Surg (London) 1894; 5: 253–6.

    Google Scholar 

  59. Hutchinson J. President’s address at the Third International Congress of Dermatology. Arch Surg (London) 1896; 7: 297–317.

    Google Scholar 

  60. Dubreuilh MW. Lentigo malin des vieillards. Ann Dermatol Syphil (Paris) 1894; 5: 1092–9.

    Google Scholar 

  61. Dubreuilh MW. De la melanose circonscrite precancereuse. Ann Dermatol Syphil 1912;3: 129–51, 205–30.

    Google Scholar 

  62. Sachs W, MacKee GM, Schwartz OD, et al. Junction nevus: nevocarcinoma. J Am Med Assoc 1947; 135: 216–8.

    Article  PubMed  CAS  Google Scholar 

  63. Becker SW. Critical evaluation of the so-called “junctional nevus.” J Invest Dermatol 1954; 22: 217–23.

    Article  CAS  Google Scholar 

  64. Mishima Y. Melanosis circumscripta praecancerosea (Dubreuilh): a non-nevoid premelanoma distinct from junction nevus. J Invest Dermatol 1960; 34: 361–75.

    PubMed  CAS  Google Scholar 

  65. Trapl J, Palecek L. Ebel J, et al. Origin and development of skin melanoblastoma on the basis of 300 cases. Acta Derm Venereol (Stockh) 1964; 44: 377–80.

    Google Scholar 

  66. Clark WH Jr. Mihm MC Jr. Lentigo maligna and lentigo maligna melanoma. Am J Pathol 1969; 55: 39–67.

    PubMed  Google Scholar 

  67. Silvers DN. Focus on melanoma: the therapeutic dilemma of lentigo maligna (Hutchinson’s freckle). J Dermatol Surg Oncol 1976; 2: 301–3.

    CAS  Google Scholar 

  68. Finan MC, Perry HO. Lentigo maligna: a form of melanoma in situ. Geriatrics 1982; 37 (12): 113–5.

    PubMed  CAS  Google Scholar 

  69. Greene A, Little JH, Weedon D. The diagnosis of Hutchinson’s melanotic freckle (lentigo Maligna) in Queensland. Pathology 1983; 15: 33–5.

    Article  Google Scholar 

  70. Cramer SF, Kiehn CL. Sequential histology study of evolving lentigo maligna melanoma. Arch Pathol Lab Med 1982; 106: 121–125.

    PubMed  CAS  Google Scholar 

  71. Cohen LM. Lentigo maligna and lentigo maligna melanoma. J Am Acad Dermatol 1995; 33: 923–36.

    Article  PubMed  CAS  Google Scholar 

  72. Cohen LM. The starburst giant cell is useful for distinguishing lentigo maligna from photo damaged skin. J Am Acad Dermatol 1996; 35: 962–67.

    Article  PubMed  CAS  Google Scholar 

  73. Somach SC, Taira FW, Pitha FV, Everett MA. Pigmented lesions in actinically damaged skin. Histopathologic comparison of biopsy and excisional specimens. Arch Dermatol 1996; 132: 1297–302.

    Article  PubMed  CAS  Google Scholar 

  74. Weyers W, Bonczkowitz M, Weyers I, et al. Melanoma in situ versus melanocytic hyperplasia in sun-damaged skin. Assessment of the significance of histopathologic criteria for differential diagnosis. J Am Acad Dermatol 1996; 18: 560–66.

    Article  CAS  Google Scholar 

  75. Cox NH, Aitchison TC, Mackie RM. Extrafacial lentigo maligna: analysis of 71 cases and comparison with lentigo maligna melanoma of the head and neck. Br J Dermatol 1998; 139: 439–43.

    Article  PubMed  CAS  Google Scholar 

  76. Acker S, Nicholson JH, Rust PF, Maize JC. Morphometric discrimination of melanoma in situ of sun-damaged skin from chronically sun-damaged skin. J Am Acad Dermatol 1998; 39: 239–45.

    Article  PubMed  CAS  Google Scholar 

  77. Allan SJ, Dicker AJ, Tidman MJ, et al. Amelanotic lentigo maligna and amelanotic lentigo maligna melanoma: a report of three cases mimicking intraepidermal squamous carcinoma. J Eur Acad Dermatol Venereol 1998; 11: 78–81.

    Article  PubMed  CAS  Google Scholar 

  78. Flotte TJ, Mihm MC. Lentigo maligna and malignant melanoma in situ, lentigo maligna type. Hum Pathol 1999; 30: 533–36.

    Article  PubMed  CAS  Google Scholar 

  79. Tannous ZS, Lerner LH, Duncan LM, et al. Progression to invasive melanoma from malignant melanoma, lentigo maligna type. Hum Pathol 2000; 31: 705–8.

    Article  PubMed  CAS  Google Scholar 

  80. Lewis MG. Malignant melanoma in Uganda (the relationship between pigmentation and malignant melanoma on the soles of the feet). Br J Cancer 1967; 21: 483–96.

    Article  PubMed  CAS  Google Scholar 

  81. Lewis MG, Kiryabwire JWN. Aspects of behavior and natural history of malignant melanoma in Uganda. Cancer 1968; 21: 876–87.

    Article  PubMed  CAS  Google Scholar 

  82. Reed RJ. Acral lentiginous melanoma. In: Reed RJ, ed. New Concepts in Surgical Pathology of Skin. New York: Wiley, 1976: 89–90.

    Google Scholar 

  83. Arrington JH III, Reed RI, Ichinose H, Krementz ET. Plantar lentiginous melanoma: a distinctive variant of human cutaneous malignant melanoma. Am J Surg Pathol 1977; 1: 131–43.

    Article  PubMed  Google Scholar 

  84. Clark WH Jr, Bernardino EA, Reed RJ, Kopf AW. Acral lentiginous melanomas including melanomas of mucous membranes. In: Clark WH Jr, Goldman LI, Mastrangelo MJ, eds. Human Malignant Melanoma. New York: Grune and Stratton, 1979: 109–24.

    Google Scholar 

  85. Coleman WP III, Loria PR, Reed RJ, Krementz ET. Acral lentiginous melanoma. Arch Dermatol 1980; 116: 773–6.

    Article  PubMed  Google Scholar 

  86. Krementz ET, Reed RJ, Coleman WP III, et al. Acral lentiginous melanoma. A clinicopathologic entity. Ann Surg 1982; 195: 632–45.

    Article  PubMed  CAS  Google Scholar 

  87. Feibleman CE, Stoll H, Maize JC. Melanomas of the palm, sole, and nailbed. Cancer 1980; 46: 2492–504.

    Article  PubMed  CAS  Google Scholar 

  88. Collins FJ. Melanoma in the Chinese of Hong Kong. Cancer 1984; 54: 1482–8.

    Article  PubMed  CAS  Google Scholar 

  89. Mishima Y, Nakanishi T. Acral lentiginous melanoma and its precursor-heterogeneity of palmo-plantar melanomas. Pathology 1985; 17: 258–65.

    Article  PubMed  CAS  Google Scholar 

  90. Scrivner D, Oxenhandler RW, Lopez M, Perez-Mesa C. Planter lentiginous melanoma. A clinicopathologic study. Cancer 1987; 60: 2502–9.

    Article  PubMed  CAS  Google Scholar 

  91. Saida T, Yoshida N, Ikegawa S, et al. Clinical guidelines for the early detection of plantar malignant melanoma. J Am Acad Dermatol 1990; 23: 37–40.

    Article  PubMed  CAS  Google Scholar 

  92. Stevens NG, Liff JM, Weiss NS. Plantar melanoma: is the incidence of melanoma of the sole of the foot really higher in blacks than whites? Int J Cancer 1990; 45: 691–93.

    Article  PubMed  CAS  Google Scholar 

  93. Tuominen L, Strengell L. Melanoma of palms, soles, and nail-beds. Scand J Plast Reconstr Hand Surg 1992; 26: 287–92.

    Article  CAS  Google Scholar 

  94. Dwyer PK, Mackie RM, Watt DC, Aitchison TC. Plantar malignant melanoma in a white population. Br J Dermatol 1993; 128: 115–20.

    Article  PubMed  CAS  Google Scholar 

  95. Kato T, Seutake T, Sugiyama Y, et al. Improvement in the survival rates of patients with acral melanoma observed in the past 22 years in Sendai, Japan. Clin Exp Dermatol 1993; 18: 107–10.

    Article  PubMed  CAS  Google Scholar 

  96. Ridgeway CA, Hieken TJ, Ronan SG, et al. Acral lentiginous melanoma. Arch Surg 1995; 130: 88–92.

    Article  PubMed  CAS  Google Scholar 

  97. Kato T, Seutake T, Sugiyama Y, et al. Clinicopathology study of acral melanoma in situ in 44 Japanese patients. Dermatology 1996; 193: 192–7.

    Article  PubMed  CAS  Google Scholar 

  98. Harmelin ES, Holcombe RN, Goggin JP, et al. Acral lentiginous melanoma. J Foot Ankle Surg 1998; 37: 540–45.

    Article  PubMed  CAS  Google Scholar 

  99. Kato T, Seutake T, Sugiyama Y, et al. Epidemiology and prognosis of plantar melanoma in 62 Japanese patients over a 28-year period. Int J Dermatol 1999; 38: 515–9.

    Article  PubMed  CAS  Google Scholar 

  100. Kuchelmeister C, Schaumburg-Lever G. Garbe C. Acral cutaneous melanoma in caucasians: clinical features, histopathology and prognosis in 112 patients. Br J Dermatol 2000; 143: 275–80.

    Article  PubMed  CAS  Google Scholar 

  101. Cho KH, Han KH, Minn KW. Superficial spreading melanoma arising in a longstanding melanocytic nevus on the sole. J Dermatol 1998; 25: 337–40.

    PubMed  CAS  Google Scholar 

  102. Saida T. Malignant melanoma on the sole: how to detect the early lesions. Pigment Cell Res 2000; 13 (Suppl 8): 135–9.

    Article  PubMed  Google Scholar 

  103. Guitart J, Lowe L, Piepkorn M, et al. Histologic characteristics of thin metastasizing melanomas: a case-control study of 43 cases. Arch Dermatol 2002; 138: 603–8.

    Article  PubMed  Google Scholar 

  104. Kang S, Barnhill RL, Mihm MC, Sober AJ. Regression in malignant melanoma: an interobserver concordance study. J Cutan Pathol 1993; 20: 126–9.

    Article  PubMed  CAS  Google Scholar 

  105. Day CL Jr, Harrist TJ, Gorstein F, et al. Malignant melanoma. Prognostic significance of “microscopic satellites” in the reticular dermis and subcutaneous fat. Ann Surg 1981; 194: 108–12.

    Article  PubMed  Google Scholar 

  106. Barnhill R, Dy K, Lugassy C. Angiotropism in cutaneous melanoma: a prognostic factor strongly predicting risk for metastasis. J Invest Dermatol. 2002; 119: 705–6.

    Article  PubMed  CAS  Google Scholar 

  107. Fitzpatrick JE. The histologic diagnosis of intraepithelial pagetoid neoplasms. Clin Dermatol 1991; 9: 255–9.

    Article  PubMed  CAS  Google Scholar 

  108. Gillman SL, Morrison RG, Hurt MA. Epidermotropic neuroendocrine carcinoma. J Cutan Pathol 1991; 18: 120–7.

    Article  Google Scholar 

  109. Cochran AJ, Wen D-R. S-100 protein as a marker for melanocytic and other tumors. Pathology 1985; 17: 340–5.

    Article  PubMed  CAS  Google Scholar 

  110. Schmitt FC, Bacchi CE. S-100 protein: Is it useful as a marker in diagnostic immunocytochemistry? Histopathology 1989; 15: 281–8.

    Article  PubMed  CAS  Google Scholar 

  111. Gown AM, Vogel AM, Hoak D, et al. Monoclonal antibodies specific for melanocytic tumors distinguish sub-populations of melanocytes. Am J Pathol 1986; 123: 195–203.

    PubMed  CAS  Google Scholar 

  112. Busam KJ, Chen YT, Old LJ, et al. Expression of melan-A (Mart-1) in benign melanocytic nevi and primary cutaneous malignant melanoma. Am J Surg Pathol 1998; 22: 976–92.

    Article  PubMed  CAS  Google Scholar 

  113. Busam KJ, Iversen K, Coplan KC, Jungbluth AA. Analysis of microphthalmia transcription factor expression in normal tissues and tumors, and comparison of its expression with S-100 protein, gp100, and tyrosinase in desmoplastic malignant melanoma. Am J Surg Pathol 2001; 25: 197204.

    Google Scholar 

  114. Boyle JL, Haupt HM, Stern JB, Multhaupt HAB. Tyrosinase expression in malignant melanoma, desmoplastic melanoma, and peripheral nerve tumors: an immunohistochemical study. Arch Pathol Lab Med 2002; 126: 816822.

    Google Scholar 

  115. Makin CA, Bobrow LG, Bodmer WF. Monoclonal anti-body to cytokeratin for use in routine histopathology. J Clin Pathol 1984; 37: 975–83.

    Article  PubMed  CAS  Google Scholar 

  116. Gullick WJ, Berger MS, Bennett PL, et al. Expression of the C-erb B2 protein in normal and transformed cells. Int J Cancer 1987; 40: 246–54.

    Article  PubMed  CAS  Google Scholar 

  117. Elder DE. Metastatic melanoma. In: Elder DE, ed. Pigment Cell. Basel: Karger, 1987; 8: 182–204.

    Google Scholar 

  118. Stern JB, Peck GL, Haupt HL, et al. Malignant melanoma in xeroderma pigmentosum: search for a precursor lesion. J Am Acad Dermatol 1993; 28: 591–94.

    Article  PubMed  CAS  Google Scholar 

  119. Barnhill RL, Flotte T, Fleischli M, Perez-Atayde AR. Childhood melanoma and atypical Spitz-tumors Cancer 1995; 76: 1833–45.

    CAS  Google Scholar 

  120. Weinstock MA, Sober AJ. The risk of progression of lentigo maligna to lentigo maligna melanoma. Br J Dermatol 1987; 116: 303–10.

    Article  PubMed  CAS  Google Scholar 

  121. Michalik EE, Fitzpatrick TB, Sober AJ. Rapid progression of lentigo maligna to lentigo maligna melanoma. Report of two cases. Arch Dermatol 1983; 119: 831–5.

    Article  PubMed  CAS  Google Scholar 

  122. Kelly JW. Following lentigo maligna may not prevent the development of life-threatening melanoma. Arch Dermatol 1992; 128: 657–60.

    Article  PubMed  CAS  Google Scholar 

  123. Gilchrest BA, Blog FB, Szabo G. Effects of aging and chronic sun exposure on melanocytes in human skin. J Invest Dermatol 1979; 73: 141–3.

    Article  PubMed  CAS  Google Scholar 

  124. Montagna W, Kirchner S, Carlisle K. Histology of sun-damaged human skin. J Am Acad Dermatol 1989; 21: 907–18.

    Article  PubMed  CAS  Google Scholar 

  125. Zimarowski MJ, Harrist TJ, Crowson AN, et al. Atypical melanocytic hyperplasia in fibrous papules mimicking lentigo maligna. Lab Invest 1994; 70: 51A.

    Google Scholar 

  126. Bastian BC, Kashani-Sabet M, Hamm H, et al. Gene amplifications characterize acral melanoma and permit the detection of occult tumor cells in the surrounding skin. Cancer Res 2000; 60: 1968–73.

    PubMed  CAS  Google Scholar 

  127. Lewis MG, Johnson K. The incidence and distribution of pigmented nevi in Ugandan Africans. Br J Dermatol 1968; 82: 362–6.

    Article  Google Scholar 

  128. Nogita T, Wong TY, Ohhara K, et al. Atypical melanosis of the foot: a report of three cases in Japanese population. Arch Dermatol 1994; 130: 1042–5.

    Article  PubMed  CAS  Google Scholar 

  129. Saida T. Heterogeneity of the site of origin of malignant melanoma in ungula areas: “subungual” malignant melanoma maybe a misnomer. Br J Dermatol 1992; 126: 529.

    PubMed  CAS  Google Scholar 

  130. Hutchinson J. Melanosis often not black: melanotic whitlow. Br Med J 1886; 1: 491.

    Google Scholar 

  131. Patterson RH, Helwig EB. Subungual malignant melanoma: a clinical-pathologic study. Cancer 1980; 46: 2074–87.

    Article  PubMed  CAS  Google Scholar 

  132. Daly JM, Berlin R, Urmacher C. Subungual melanoma: a 25-year review of cases. J Surg Oncol 1987; 35: 107–112.

    Article  PubMed  CAS  Google Scholar 

  133. Saida T, Ohshima Y. Clinical and histopathologic characteristics of early lesions of subungual malignant melanoma. Cancer 1989; 63: 556–60.

    Article  PubMed  CAS  Google Scholar 

  134. Blessing K, Kernohan NM, Park KGM. Subungual malignant melanoma: clinicopathological features of 100 cases. Histopathology 1992; 19: 425–9.

    Article  Google Scholar 

  135. Rigby HS, Briggs JC. Subungual melanoma: A clinicopathological study of 24 cases. Br J Plast Surg 1992; 45: 275–8.

    Article  PubMed  CAS  Google Scholar 

  136. Krige JEJ, Hudson DA, Johnson CA, et al. Subungual melanoma. S Afr J Surg 1995; 33: 10–14.

    PubMed  CAS  Google Scholar 

  137. Kato T, Seutake T, Sugiyama Y, et al. Epidemiology and prognosis of subungual melanoma in 34 Japanese patients. Br J Dermatol 1996; 134: 383–7.

    Article  PubMed  CAS  Google Scholar 

  138. Quinn MJ, Thompson JE, Crotty K, et al. Subungual melanoma of the hand. J Hand Surg 1996; 21: 506–11.

    Article  CAS  Google Scholar 

  139. Glat PM, Spector JA, Roses DF, et al. The management of pigmented lesions of the nail bed. Ann Plast Surg 1996; 37: 125–34.

    Article  PubMed  CAS  Google Scholar 

  140. Levit EK, Kagen MH, Scher RK, et al. The ABC rule for clinical detection of subungual melanoma. J Am Acad Dermatol 2000; 42: 269–74.

    Article  PubMed  CAS  Google Scholar 

  141. Baran R, Kechijian P. Longitudinal melanonychia (melanonychia striata): diagnosis and management. J Am Acad Dermatol 1989; 21: 1165–75.

    Article  PubMed  CAS  Google Scholar 

  142. Baran R, Kechijian P. Hutchinson’s sign: a reappraisal. J Am Acad Dermatol 1996; 34: 87–90.

    Article  PubMed  CAS  Google Scholar 

  143. Caron GA. Familial congenital pigmented nevi of nails. Lancet 1982; 1: 508–9.

    Google Scholar 

  144. Kato T, Usuba Y, Takematso H, et al. Rapidly growing nail streak resulting in diffuse melanosis of the nail: a possible sign of subungual melanoma in situ. Cancer 1989; 64: 2191–7.

    Article  PubMed  CAS  Google Scholar 

  145. Kichuki, I, Inoue S, Sakaguchi E, One R. Regressing nail melanosis in childhood. Dermatology 1993; 186: 88–93.

    Article  Google Scholar 

  146. Pomerance J, Kopf AW, Ramos L, et al. A large pigmented nail bed lesion in a child. Ann Plast Surg 1994; 33: 80–2.

    Article  PubMed  CAS  Google Scholar 

  147. Conley J, Lattes R, Orr W. Desmoplastic malignant melanoma (a rare variant of spindle cell melanoma). Cancer 1971; 28: 914–36.

    Article  PubMed  CAS  Google Scholar 

  148. Labrecque PG, Hu C, Winkelmann RK. On the nature of desmoplastic melanoma. Cancer 1976; 38: 1205–13.

    Article  PubMed  CAS  Google Scholar 

  149. Valensi QJ. Desmoplastic malignant melanoma. A report of two additional cases. Cancer 1977; 39: 286–92.

    Article  PubMed  CAS  Google Scholar 

  150. Valensi QJ. Desmoplastic malignant melanoma. A light and electron microscopic study of two cases. Cancer 1979; 43: 1148–55.

    Article  PubMed  CAS  Google Scholar 

  151. Valensi QJ. Desmoplastic malignant melanoma: study of a case by light and electronmicroscopy. J Dermatol Surg Oncol 1979; 5: 31–5.

    PubMed  CAS  Google Scholar 

  152. Bryant E, Ronan SG, Felix EL, Manaligod JR. Desmoplastic malignant melanoma. A study by conventional and electron microscopy. Am J Dermatopathol 1982; 4: 467–74.

    Article  PubMed  CAS  Google Scholar 

  153. From L, Hanna W, Kahn HI, et al. Origin of the desmoplasia in desmoplastic malignant melanoma. Hum Pathol 1983; 14: 1072–80.

    Article  PubMed  CAS  Google Scholar 

  154. Reiman HM, Goellner JR, Woods JE, Mixter RC. Desmoplastic melanoma of the head and neck. Cancer 1987; 60: 2269–74.

    Article  PubMed  CAS  Google Scholar 

  155. Egbert B, Kempson R, Sagebiel R. Desmoplastic malignant melanoma. A clinico-histopathologic study of 25 cases. Cancer 1988; 62: 2033–41.

    Article  PubMed  CAS  Google Scholar 

  156. Walsh NM, Roberts JT, Orr W, Simon GT. Desmoplastic malignant melanoma. A clinico-pathologic study of 14 cases. Arch Pathol Lab Med 1988; 112: 922–7.

    PubMed  CAS  Google Scholar 

  157. Beenken S, Byers R, Smith JL, et al. Desmoplastic melanoma. Histologic correlationwith behavior and treatment. Arch Otolaryngol Head Neck Surg 1989; 115: 374–9.

    Article  PubMed  CAS  Google Scholar 

  158. Jain S, Allen PW. Desmoplastic malignant melanoma and its variants. A study of 45 cases. Am J Surg Pathol 1989; 13: 358–73.

    Article  PubMed  CAS  Google Scholar 

  159. Smithers BM, McLeod GR, Little JH. Desmoplastic, neural transforming and neurotropic melanoma: A review of 45 cases. Aust N Z J Surg 1990; 60: 967–72.

    Article  PubMed  CAS  Google Scholar 

  160. Bruijn JA, Mihm MC Jr, Barnhill RL. Desmoplastic melanoma. Histopathology 1992; 20: 197–205.

    Article  PubMed  CAS  Google Scholar 

  161. Bruijn JA, Salasche SJ, Sober AJ, et al. Desmoplastic melanoma: clinicopathologic aspects of six cases. Dermatology 1992; 185: 3–8.

    Article  PubMed  CAS  Google Scholar 

  162. Anstey A, McKee P, Wilson Jones E. Desmoplastic malignant melanoma: a clinicopathologic study of 25 cases. Br J Dermatol 1993; 129: 359–71.

    Article  PubMed  CAS  Google Scholar 

  163. Carlson JA, Dickerson GR, Sober AJ, Barnhill RL. Desmoplastic neurotropic malignant melanoma: A clinicopathologic analysis of 28 cases. Cancer 1995; 75: 478–94.

    Article  PubMed  CAS  Google Scholar 

  164. Baer SC, Schultz D, Synnestvedt M, Elder DE. Desmoplasia and neurotopism: prognostic variables in patients with stage I melanoma. Cancer 1995; 76: 2242–7.

    Article  PubMed  CAS  Google Scholar 

  165. Skelton HG, Smith KJ, Laskin WB, et al. Desmoplastic malignant melanoma. J Acad Dermatol 1995; 32: 717–25.

    Article  CAS  Google Scholar 

  166. Longacre TA, Egbert BM, Rouse RV. Desmoplastic and spindle cell malignant melanoma. An immunohistochemical study. Am J Surg Pathol 1996; 20: 1489–500.

    Article  PubMed  CAS  Google Scholar 

  167. Kilpatrick SC, White WL, Browne JD. Desmoplastic malignant melanoma of the oral mucosal: an underrecognized diagnostic pitfall. Cancer 1996; 78: 383–9.

    Article  PubMed  CAS  Google Scholar 

  168. Tsao H, Sober AJ, Barnhill RL. Desmoplastic neurotropic melanoma. Semin Cutan Med Surg 1997; 16: 131–6.

    Article  PubMed  CAS  Google Scholar 

  169. Quinn MJ, Crotty KA, Thompson JF, et al. Desmoplastic and desmoplastic neurotropic melanoma: experience with 280 patients. Cancer 1999; 83: 1128–35.

    Article  Google Scholar 

  170. Reed RJ, Leonard DD. Neurotropic melanoma: a variant of desmoplastic melanoma. Am J Surg Pathol 1979; 3: 301–11.

    Article  PubMed  CAS  Google Scholar 

  171. Kossard S, Doherty E, Murray E. Neurotropic melanoma. A variant of desmoplastic melanoma. Arch Dermatol 1987; 123: 907–12.

    Article  PubMed  CAS  Google Scholar 

  172. Barnhill RL, Fine J, Roush GC, Berwick M. Predicting five-year outcome from cutaneous melanoma in a population-based study. Cancer 1996; 78: 427–32.

    Article  PubMed  CAS  Google Scholar 

  173. Kanik AB, Yaar M, Bhawan J. p75 nerve growth factor receptor staining helps identifiy desmoplastic and neurotropic melanoma. J Cutan Pathol 1996; 23: 205–10.

    CAS  Google Scholar 

  174. Iwamoto S, Burrows RC, Agoff SN, et al. The p75 neurotrophin receptor, relative to other Schwann cell and melanoma markers, is abundantly expressed in spindled melanomas. Am J Dermatopathol 2001; 23: 288–94.

    Article  PubMed  CAS  Google Scholar 

  175. Warner TCS, Hafez GR, Finch RE, Schwann cell features in neurotropic melanoma. J Cutan Pathol 1981; 8: 177–87.

    Article  PubMed  CAS  Google Scholar 

  176. DiMaio SM, Mackay BM, Smith JL, Dickerson GR. Neurosarcomatous transformation in malignant melanoma. Cancer 1982; 50: 2345–54.

    Article  PubMed  CAS  Google Scholar 

  177. Gentile RD, Donovan DT. Neurotropic melanoma of the head and neck. Laryngoscope 1985; 85: 1161–6.

    Google Scholar 

  178. Mack EE, Gomez EC. Neurotropic melanoma. J NeuroOncol 1992; 13: 165–71.

    Article  PubMed  CAS  Google Scholar 

  179. Barnhill RL, Sagebiel RW, Lugassy C. Angiotropic melanoma: report of seven additional cases J Cutan Pathol. 2000; 27: 548. 12

    Google Scholar 

  180. Barnhill RL, Bolognia JL. Neurotropic melanoma with prominent melanization. J Cutan Pathol 1995; 22: 450–9.

    Article  PubMed  CAS  Google Scholar 

  181. Warner TF, Lloyd RV, Hafez GR, Angevine JM. Immunocytochemistry of neurotropic melanoma. Cancer 1984; 53: 254–57.

    Article  PubMed  CAS  Google Scholar 

  182. Anstey A, Cerio R, Rammarain N, et al. Desmoplastic malignant melanoma, an immunocytochemical study of 23 cases. Am J Dermatopathol 1994; 16: 14–22.

    Article  PubMed  CAS  Google Scholar 

  183. Eng W, Tschen JA. Comparison of S-100 versus hematoxylin and eosin staining for evaluating dermal invasion and peripheral margins by desmoplastic malignant melanoma. Am J Dermatopathol 2000; 22: 26–9.

    Article  PubMed  CAS  Google Scholar 

  184. Wick MR, Swanson PE, Rocamora A. Recognition of malignant melanoma by monoclonal antibody HMB-45. An immunohistochemical study of 200 paraffin-embedded cutaneous tumors. J Cutan Pathol 1988; 15: 201–7.

    Article  PubMed  CAS  Google Scholar 

  185. AL-Alousi S, Carlson JA, Blessing K, et al. Expression of basic fibroblast growth factor in desmoplastic neurotropic malignant melanoma. J Cutan Pathol 1996; 23: 118–25.

    Article  Google Scholar 

  186. Xu X, Chu AY, Pasha TL, et al. Immunoprofile of MITF, tyrosinase, Melan-a, and MAGE-1 in HMB45-negative melanomas. Am J Surg Pathol 2002; 26 (1): 82–7.

    Article  PubMed  Google Scholar 

  187. Gartner MFRM, Fearns C, Wilson EL, et al. Unusual growth characteristics of human melanoma xenografts in the nude mouse: a model for desmoplasia, dormancy and progression. Br J Cancer 1992; 64: 487–90.

    Article  Google Scholar 

  188. Fearns C, Dowdle EB. The desmoplastic response: induction of collagen synthesis by melanoma cells in vitro. Int J Cancer 1992; 50: 621–7.

    Article  PubMed  CAS  Google Scholar 

  189. Gutzmer R, Herbst RA, Mommert S, et al. Allelic loss at the neurofibromatosis type 1 (NF1) gene locus is frequent in desmoplastic neurotropic melanoma. Hum Genet 2000; 107: 357–61.

    Article  PubMed  CAS  Google Scholar 

  190. Smithers BM, McLeod GR, Little JH. Desmoplastic melanoma: patterns of recurrence. World J Surg 1992; 16: 186–90.

    Article  PubMed  CAS  Google Scholar 

  191. Jaroszewski DE, Pockaj BA, DiCaudo DJ, Bite U. The clinical behavior of desmoplastic melanoma. Am J Surg 2001; 186 (6): 590–5.

    Article  Google Scholar 

  192. Payne WG, Kearney R, Wells K, et al. Desmoplastic melanoma. Am Surg 2001; 67: 1004–6.

    PubMed  CAS  Google Scholar 

  193. Mihm MC, Googe PB. Problems in various subtypes of malignant melanoma. In: Mihm MC, Googe PB, eds. Problematic Pigmented Lesions-A Case Method Approach. Philadelphia: Lea and Febiger, 1990: 279–370.

    Google Scholar 

  194. Barr RJ, Morales RV, Graham JH. Desmoplastic nevus. A distinct histologic variant of mixed spindle cell and epithelioid cell nevus. Cancer 1980; 46: 557–64.

    Article  PubMed  CAS  Google Scholar 

  195. Barnhill RL, Mihm MC. Cellular neurothekeoma: a distinctive variant of neurothekeoma mimicking nevomelanocytic tumors. Am J Surg Pathol 1990; 14: 113–20.

    Article  PubMed  CAS  Google Scholar 

  196. Kaneishi ND, Cockerell CJ. Histologic differentiation of desmoplastic melanoma from cicatrices. Am J Dermatopathol 1998; 20: 128–34.

    Article  PubMed  CAS  Google Scholar 

  197. Robson A, Allen P, Hollowood K. S 100 expression in cutaneous scars: a potential diagnostic pitfall in the diagnosis of desmoplastic melanoma. Histopathology 2002; 38: 135–40.

    Article  Google Scholar 

  198. Recamier JCA. Recherches sur le Traitement du Cancer. Paris: Gabon, 1829.

    Google Scholar 

  199. Lugassy C, Escande JP. The hematogenous theory of metastasis: Recamier did not propose it. Virchows Arch 1997; 431: 371.

    Article  Google Scholar 

  200. Handley WS. The pathology of melanotic growths in relation to their operative treatment. Lancet 1907; 927: 996–8.

    Google Scholar 

  201. Lugassy C, BP Eyden, L Christensen, JP Escande. Angiotumoral complex in human malignant melanoma characterised by free laminin: ultrastructural and immuno-histochemical observations. J Submicrosc Cytol Pathol 1997; 29: 19–28.

    PubMed  CAS  Google Scholar 

  202. Lugassy C, Christensen L, Le Charpentier M, et al. Ultra-structural and immunohistological observations concerning laminin in B16 melanoma: is an amorphous form of laminin promoting a non hematogenous migraton of tumor cells? J Submicrosc Cytol Pathol 1998; 30: 137–44.

    PubMed  CAS  Google Scholar 

  203. Lugassy C, Christensen L, Le Charpentier M, et al. Angiotumoral laminin in murine tumors derived from human melanoma cell lines. Immunohistochemical and ultra-structural observations. J Submicrosc Cytol Pathol 1998; 30 (2): 231–7.

    PubMed  CAS  Google Scholar 

  204. Lugassy C, Dickersin GR, Christensen L, et al. Ultrastructural and immunohistochemical studies of the periendothelial matrix in malignant melanoma: evidence for an amorphous matrix containing laminin. J Cutan Pathol 1999; 26: 78–83.

    Article  PubMed  CAS  Google Scholar 

  205. Lugassy C, Shahsafaei A, Bonitz P, et al. Tumor microvessels in melanoma express the beta-2 chain of laminin. Implications for melanoma metastasis. J Cutan Pathol 1999; 26: 222–6.

    Article  PubMed  CAS  Google Scholar 

  206. Moreno A, Espanol I, Romagosa V. Angiotropic malignant melanoma. Report of two cases. J Cutan Pathol 1992; 19: 325–9.

    Article  PubMed  CAS  Google Scholar 

  207. Shea CR, Kline MA, Lugo J, McNutt NS. Angiotropic metastatic malignant melanoma. Am J Dermatopathol 1995; 17: 58–62.

    Article  PubMed  CAS  Google Scholar 

  208. Saluja A. Moncy N, Zivony DI, Solomon AR. Angiotropic malignant melanoma: a rare pattern of local metastases. J Am Acad Dermatol 2001; 44: 829–32.

    Article  PubMed  CAS  Google Scholar 

  209. Lugassy C, Kleinman HK, Fernandez PM, et al. Human melanoma cell migration along capillary-like structures in vitro: a new dynamic model for studying extravascular migratory metastasis. J Invest Dermatol 2002; 119: 703–4.

    Article  PubMed  CAS  Google Scholar 

  210. Lugassy C, Haroun RI, Brem H, et al. Pericytic-like angiotropism of glioma and melanoma cells. Am J Dermatopathol 2002; 24: 473–8.

    Article  PubMed  Google Scholar 

  211. Reed RJ, Ichinose H, Clark WH Jr, Mihm MC Jr. Common and uncommon melanocytic nevi and borderline melanomas. Semin Oncol 1975; 2: 119–47.

    PubMed  CAS  Google Scholar 

  212. Reed RJ. Consultation case. Am J Surg Pathol 1978; 2: 215–20.

    Article  PubMed  CAS  Google Scholar 

  213. Hendrickson MR, Ross JC. Neoplasms arising in congenital giant nevi: morphologic study of seven cases and a review of the literature. Am J Surg Pathol 1981; 5: 109–35.

    Article  PubMed  CAS  Google Scholar 

  214. Muhlbauer JE, Margolis RJ, Mihm MC Jr, Reed RJ. Minimal deviation melanoma: a histologic variant of cutaneous malignant melanoma in its vertical growth phase. J Invest Dermatol 1983; 80 (Suppl): 63S - 5S.

    Article  CAS  Google Scholar 

  215. Phillips ME, Margolis RJ, Merot Y, et al. The spectrum of minimal deviation melanoma: a clinicopathologic study of 21 cases. Hum Pathol 1986; 17: 796–806.

    Article  PubMed  CAS  Google Scholar 

  216. Reed RJ. Minimal deviation melanoma. In: Mihm MC Jr, Murphy GF, Kaufman N, eds. Pathobiology and Recognition of Malignant Melanoma. Baltimore: Williams and Wilkins, 1988: 110–52.

    Google Scholar 

  217. Reed RJ, Webb S, Clark WH Jr. Minimal deviation melanoma (halo nevus variant). Am J Surg Pathol 1990; 14: 53–68.

    Article  PubMed  CAS  Google Scholar 

  218. Larsen TE, Grude TH. A retrospective histologic study of 669 cases of primary cutaneous malignant melanoma in clinical stage I: II. The relation of cell type, pigmentation, atypia, and mitotic count to histologic type and prognosis. Acta Pathol Microbiol Scand A 1978; 86: 513–22.

    Google Scholar 

  219. Day CL, Harrist TJ, Lew RA, Mihm MC Jr. Classification of malignant melanoma according to the histologic morphology of melanoma nodules. J Dermatol Surg Oncol 1982; 8: 874–5, 900.

    Google Scholar 

  220. Baak JP, Tan G. The adjuvant prognostic value of nuclear morphometry in stage I malignant melanoma of the skin: a multivariate analysis. Anal Quant Cytol Histol 1986; 68: 241–4.

    Google Scholar 

  221. Sorensen FB. Objective histopathologic grading of cutaneous malignant melanomas by stereologic estimation of nuclear volume. Cancer 1989; 63: 1784–98.

    Article  PubMed  CAS  Google Scholar 

  222. Schmoeckel C, Castro CE, Braun-Falco O. Nevoid malignant melanoma. Arch Dermatol Res 1985; 277: 362–9.

    Article  PubMed  CAS  Google Scholar 

  223. Levene A. On the histological diagnosis and prognosis of malignant melanoma. J Clin Pathol 1980; 33: 101–24.

    Article  PubMed  CAS  Google Scholar 

  224. Suster S, Ronnen M, Bubis JJ. Verrucous pseudonevoid melanoma. J Surg Oncol 1987; 36: 134–7.

    Article  PubMed  CAS  Google Scholar 

  225. Kuehnl-Petzoldt C, Berger H, Wiebelt H. Verrucous-keratotic variations of malignant melanoma. A clinicopathological study. Am J Dermatopathol 1982; 4: 403–10.

    PubMed  CAS  Google Scholar 

  226. Blessing K, Evans AT, Al-Nafussi A. Verrucous nevoid and keratotic malignant melanoma: a clinico-pathological study of 20 cases. Histopathology 1993; 23: 453–8.

    Article  PubMed  CAS  Google Scholar 

  227. Wong TY, Duncan LM, Mihm MCJ. Melanoma mimicking dermal and Spitz’s nevus (“nevoid” melanoma). Semin Surg Oncol 1993; 9: 188–93.

    PubMed  CAS  Google Scholar 

  228. Wong TY, Suster S, Duncan LM, et al. Nevoid melanoma: a clinicopathological study of seven cases of malignant melanoma mimicking spindle and epithelioid cell nevus and verrucous dermal nevus. Hum Pathol 1995; 26: 171–9.

    Article  PubMed  CAS  Google Scholar 

  229. McNutt NS, Urmacher C, Hakimian J, et al. Nevoid malignant melanoma: morphologic patterns and immunohistochemical reactivity. J Cutan Pathol 1995; 22: 502–17.

    Article  PubMed  CAS  Google Scholar 

  230. McNutt NS. “Triggered trap”: nevoid malignant melanoma. Semin Diagn Pathol 1998;15:203–9.

    Google Scholar 

  231. Zembowicz A, McCusker M, Chiarelli C, et al. Morphological analysis of nevoid melanoma: a study of 20 cases with a review of the literature. Am J Dermatopathol 2001; 23: 167–75.

    Article  PubMed  CAS  Google Scholar 

  232. Steiner A, Konrad K, Pehamberger H, Wolff K. Verrucous malignant melanoma. Arch Dermatol 1988; 124: 1534–7.

    Article  PubMed  CAS  Google Scholar 

  233. Barnhill RL. Childhood melanoma. Semin Diagn Pathol 1998; 15: 189–94.

    PubMed  CAS  Google Scholar 

  234. Spatz A, Barnhill RL. Small cell melanoma in childhood. Pathol Case Rev 1999; 4: 102–6.

    Article  Google Scholar 

  235. Blessing K, Grant JJH, Sanders SDA, et al. Small cell malignant melanoma: a variant of naevoid melanoma. Clinicopathological features and histological differential diagnosis. J Clin Pathol 2000; 53: 591–5.

    Article  PubMed  CAS  Google Scholar 

  236. Kossard S, Wilkinson B. Nucleolar organizer regions and image analyis nuclear morphometry of small cell (nevoid) melanoma. J Cutan Pathol 1995; 22: 132–6.

    Article  PubMed  CAS  Google Scholar 

  237. Kossard S, Wilkinson B. Small cell (naevoid) melanoma: a clinicopathologic study of 131 cases. Austral J Dermatol 1997; 38 (Suppl): S54–8.

    Google Scholar 

  238. Siegelman-Danieli N, Cohen HI, Ben-Izhack O. Malignant skin lesions. Case 1: nevoid malignant melanoma of the breast presenting as a contralateral breast metastasis. J Clin Oncol 1999; 17: 3850–2.

    Google Scholar 

  239. House N, Fedok F, Maloney ME, Helm KF. Malignant melanoma with clinical and histologic features of Merkel cell carcinoma. J Am Acad Dermatol 1994; 31: 839–42.

    Article  PubMed  CAS  Google Scholar 

  240. Okun MR. Melanoma resembling spindle and epithelioid cell nevus. Arch Dermatol 1979; 115: 1416–20.

    Article  PubMed  CAS  Google Scholar 

  241. Busam KJ, Barnhill RL. Spitz nevus and spitzoid melanoma. In: Kirkham N, Lemoine N. Progress in Pathology. Churchill Livingstone, 1995; 2: 31–46.

    Google Scholar 

  242. Barnhill RL, Argenyi ZB, From L et al. Atypical Spitz nevi/tumors: lack of consensus for diagnosis, discrimination from melanoma, and prediction of outcome. Hum Pathol 1999; 30: 513–20.

    Article  PubMed  CAS  Google Scholar 

  243. Okun M, Bauman L. Malignant melanoma arising from an intradermal nevus. Arch Dermatol 1965; 92: 69–72.

    Article  PubMed  CAS  Google Scholar 

  244. Okun MR, Di Mattia A, Thompson J, Pearson SH. Malignant melanoma developing from intradermal nevi. Arch Dermatol 1974; 110: 599–601.

    Article  PubMed  CAS  Google Scholar 

  245. Benisch B, Peison B, Kannerstein M, Spivack J. Malignant melanoma originating from intradermal nevi. A clinicopathologic entity. Arch Dermatol 1980; 116: 696–8.

    Article  PubMed  CAS  Google Scholar 

  246. Ball NJ, Golitz LE. Melanocytic nevi with focal atypical epithelioid cell components: a review of seventy-three cases. J Am Acad Dermatol. 1994; 30: 724–9.

    Article  PubMed  CAS  Google Scholar 

  247. Collina G, Deen S, Cliff S, et al. Atypical dermal nodules in benign melanocytic naevi. Histopathology 1997; 31: 77–101.

    Article  Google Scholar 

  248. Coffey RJ, Berkeley WT. Prepubertal malignant melanoma. J Am Med Assoc 1951; 147: 846–9.

    Article  PubMed  CAS  Google Scholar 

  249. Allen A, Spitz S. Malignant melanoma. A clinicopathological analysis of the criteria for diagnosis and prognosis. Cancer 1953; 6: 1–45.

    Article  PubMed  CAS  Google Scholar 

  250. Fisher ER. Malignant blue naevus. Arch Dermatol 1956; 74: 227–31.

    Article  CAS  Google Scholar 

  251. Kerstin DW, Caro MR. Cellular blue nevus of Ota followed for 22 years. AMA Arch Derm 1956; 74: 539–47.

    Google Scholar 

  252. Kwittken J, Negri L. Malignant blue nevus: case report of a Negro woman. Arch Dermatol 1966; 94: 64–9.

    Article  PubMed  CAS  Google Scholar 

  253. Leopold JG, Richards DB. Cellular blue naevi. J Pathol Bacteriol 1967; 94: 247–55.

    Article  PubMed  CAS  Google Scholar 

  254. Rodriguez HA, Ackerman LV. Cellular blue nevus. Cancer 1968; 21: 393–405.

    Article  PubMed  CAS  Google Scholar 

  255. Merkow LP, Burt RC, Hayeslip DW, et al. A cellular and malignant blue nevus. A light and electron microscopic study. Cancer 1969; 24: 888–96.

    Article  PubMed  CAS  Google Scholar 

  256. Mishima Y. Cellular blue nevus: melanogenic activity and malignant transformation. Arch Derm 1970; 101: 104–10.

    Article  PubMed  CAS  Google Scholar 

  257. Hourihane DO’B. Malignant blue nevus with metastasis to regional lymph node. Ir J Med Sci 1971; 140: 169–75.

    Article  Google Scholar 

  258. Silverberg G, Kadin MF, Dorfman RF, et al. Invasion of the brain by a cellular blue nevus of the scalp: a case report with light and electron microscopic studies. Cancer 1971; 27: 349–55.

    Article  PubMed  CAS  Google Scholar 

  259. Hernandez JF. Malignant blue nevus: a light and electron microscopic study. Arch Dermatol 1973; 107: 741–4.

    Article  PubMed  CAS  Google Scholar 

  260. Speakman JS, Phillips MJ. Cellular and malignant blue nevus complicating oculodermal melanosis (nevus of Ota syndrome). Can J Ophtalmol 1973; 8: 539–47.

    CAS  Google Scholar 

  261. Levene A. On the natural history and comparative pathology of the blue naevus. Ann R Coll Surg 1980; 62: 327–34.

    CAS  Google Scholar 

  262. Rubinstein N, Kopolovic J, Wexler MR, Peled IJ. Malignant blue nevus. J Dermatol Surg Oncol 1985; 11: 921–3.

    PubMed  CAS  Google Scholar 

  263. Wetherington GM, Norin AL, Sadove AM. Locally invasive cellular blue nevus of the scalp. Plast Reconstr Surg 1987; 79: 114–7.

    Article  PubMed  CAS  Google Scholar 

  264. Temple-Camp CRE, Saxe N, King H. Benign and malignant cellular blue nevus: a clinicopathologic study of 30 cases. Am J Dermatopathol 1988; 10: 289–96.

    Article  PubMed  CAS  Google Scholar 

  265. Goldenhersh MA, Savin RC, Barnhill RL, Stenn KS. Malignant blue nevus. Case report and literature review. J Am Acad Dermatol 1988; 19: 712–22.

    Article  PubMed  CAS  Google Scholar 

  266. Kuhn, A, Groth W. Garmann H, Steigleder GK. Malignant blue nevus with metastases to the lung. Am J Dermatopathol 1988; 10 (5): 436–41.

    PubMed  CAS  Google Scholar 

  267. Shallman RW, Hoehn JL, Lawton BR, Dickson KB. Malignant cellular blue nevus: unusual case of a rare tumor. Wisc Med J 1988; 87: 16–8.

    CAS  Google Scholar 

  268. Modly C, Wood C, Horn T. Metastatic malignant melanoma arising from a common blue nevus in a patient with subacute cutaneous lupus erythematosus. Dermatological 1989; 178: 171–5.

    Article  CAS  Google Scholar 

  269. Boi S, Barbareschi M, Vigl E, Cristofolini M. Malignant blue nevus: report of four new cases and review of the literature. Histol Histopathology 1991; 6: 427–34.

    CAS  Google Scholar 

  270. Connelly J, Smith JL Jr. Malignant blue nevus. Cancer 1991; 67: 2653–7.

    Article  PubMed  CAS  Google Scholar 

  271. Mehregan DA, Gibson LE, Mehregan AH. Malignant blue nevus: a report of eight cases. J Dermatol Sci 1992; 4: 185–92.

    Article  PubMed  CAS  Google Scholar 

  272. Pich A, Chiusa L, Margaria E, Aloi F. Proliferative activity in the malignant cellular blue nevus. Hum Pathol 1993; 24: 1323–9.

    Article  PubMed  CAS  Google Scholar 

  273. Pathy AL, Helm TN, Elston D, et al. Malignant melanoma arising in a blue nevus with features of pilar neurocristic hamartoma. J Cutan Pathol 1993; 20: 459–64.

    Article  PubMed  CAS  Google Scholar 

  274. Scott GA, Trepeta R. Clear cell sarcoma of tendons and aponeuroses and malignant blue nevus arising in prepubescent children: report of two cases and review of the literature. Am J Dermatopathol 1993; 15: 139–45.

    Article  PubMed  CAS  Google Scholar 

  275. Aloi E, Pich A, Pippione M. Malignant cellular blue nevus: a clinicopathological study of 6 cases. Dermatology 1996; 192: 36–40.

    Article  PubMed  CAS  Google Scholar 

  276. Koch H, Cerroni L, Soyer HP, Kera H. Zelger B. Malignant blue nevus: malignant melanoma in association with blue nevus. Eur J Dermatol 1996; 6: 335–8.

    Google Scholar 

  277. Spatz A, Zimmermann U, Bachollet B, et al. Malignant blue nevus of the vulva with late ovarian metastatis. Am J Dermatopathol 1998; 20: 408–12.

    Article  PubMed  CAS  Google Scholar 

  278. Calista D, Schianchi S, Landi C. Malignant blue nevus of the scalp. Int J Dermatol 1998; 37: 126–7.

    Article  PubMed  CAS  Google Scholar 

  279. Duteille F, Duport G, Larregue M, et al. Malignant blue nevus: three new cases and a review of the literature. Ann Plast Surg 1998; 41: 674–8.

    Article  PubMed  CAS  Google Scholar 

  280. Granter SR, McKee PH, Calonje E, et al. Melanoma associated with blue nevus and melanoma mimicking cellular blue nevus: a clinicopathologic study of 10 cases on the spectrum of so-called `malignant blue nevus’. Am J Surg Pathol 2001; 25: 316–23.

    Article  PubMed  CAS  Google Scholar 

  281. Avidor I, Kessler E. “Atypical” blue nevus-a benign variant of cellular blue nevus. Dermatologica 1977; 154: 39–44.

    CAS  Google Scholar 

  282. Goette DK, Robinson JW. Atypical cellular blue nevus. J Assoc Militar Dermatol 1980; 4 (1): 6–8.

    Google Scholar 

  283. Tran TA, Carlson JA, Basaca B, Mihm MC Jr. Cellular blue nevus with atypia (atypical cellular blue nevus): a clinicopathologic study of nine cases. J Cutan Pathol 1998; 25: 252–8.

    Article  PubMed  CAS  Google Scholar 

  284. Busam KJ, Woodruff JM, Erlandson RA, Brady MS. Large plaque-type blue nevus with subcutaneous cellular nodules. Am J Surg Pathol 2000; 24 (1): 92–9.

    Article  PubMed  CAS  Google Scholar 

  285. Lamovec J. Blue nevus of the lymph node capsule: report of a new case with review of the literature. Am J Clin Pathol 1984; 81: 367–72.

    PubMed  CAS  Google Scholar 

  286. Epstein JI, Erlandson RA, Rosen PP. Nodal blue nevi: a study of three cases. Am J Surg Pathol 1984; 8: 907–15.

    Article  PubMed  CAS  Google Scholar 

  287. Lambert WC, Brodkin RH. Nodal and subcutaneous cellular blue nevi: A pseudometastasizing pseudomelanoma. Arch Dermatol 1984; 120: 367–70.

    Article  PubMed  CAS  Google Scholar 

  288. Sterchi JM, Muss HB, Weidner N. Cellular blue nevus simulating metastatic melanoma: report of an unusually large lesion associated with nevus-cell aggregates in regional lymph nodes. J Surg Oncol 1987; 36: 71–5.

    Article  PubMed  CAS  Google Scholar 

  289. Enzinger FM. Clear-cell sarcoma of tendons and aponeuroses: an analysis of 21 cases. Cancer 1965; 18: 1163–74.

    Article  PubMed  CAS  Google Scholar 

  290. Chung EB, Enzinger FM. Malignant melanoma of soft parts: a reassepagetoid melanomaent of clear-cell sarcoma. Am J Surg Pathol 1983; 7: 405–13.

    Article  PubMed  CAS  Google Scholar 

  291. Swanson PE, Wick MR. Clear cell sarcoma. An immunohistochemical analysis of six cases and comparison with other epithelioid neoplasms of soft tissue. Arch Pathol Lab Med 1989; 113: 55–60.

    PubMed  CAS  Google Scholar 

  292. Sara AS, Evans HL, Benjamin RS. Malignant melanoma of soft parts (clear cell sarcoma): a study of 17 cases, with emphasis on prognostic factors. Cancer 1990; 65: 367–74.

    Article  PubMed  CAS  Google Scholar 

  293. Zucman J, Delattre O, Cesmaze C, et al. EWS and ATF-1 gene fusion induced by t(12;22) translocatio in malignant melanoma of soft parts. Nat Genet 1993; 4: 341–5.

    Article  PubMed  CAS  Google Scholar 

  294. Van Roggen JFG, Mooi WJ, Hogendoorn PCS. Clear cell sarcoma of tendons and aponeurosis (malignant melanoma of soft parts) and cutaneous melanoma: exploring the histogenetic relationship between these two clinicopatholgical entities. J Pathol 1998; 186: 3–7.

    Article  Google Scholar 

  295. Deenik W, Mooi WJ, Rutgers EJ, et al. Clear cell sarcoma (malignant melanoma) of soft parts: a clinicopathologic study of 30 cases. Cancer 1999; 86: 969–75.

    Article  PubMed  CAS  Google Scholar 

  296. Finley JW, Hanypsiak B, McGrath B, et al. Clear cell sarcoma: the Roswell Park experience. J Surg Oncol 2001; 77: 16–20.

    Article  PubMed  CAS  Google Scholar 

  297. Langezaal SM, van Roggen JFG, Cleton-Jansen AM, et al. Malignant melanoma in genetically distinct from clear cell sarcoma of tendons and aponeurosis (malignant melanoma of soft parts). Br J Cancer 2001; 84: 535–538.

    Article  PubMed  CAS  Google Scholar 

  298. Panagopoulos I, Mertens F, Debiec-Rychter M, et al. Molecular genetic characterization of the EWS/AFT1 fusion gene in clear cell sarcoma of tendons and aponeuroses. Int J Cancer. 2002; 99: 560–7.

    Article  PubMed  CAS  Google Scholar 

  299. Ferrari A, Casanova M, Bisogno G, et al. Clear cell carcinoma of tendons and aponeurosis in pediatric patients: a report from the Italian and German soft tissue sarcoma cooperative group. Cancer 2002; 94: 3269–76.

    Article  PubMed  Google Scholar 

  300. Nakhleh RE, Wick MR, Rocamora A, et al. Morphologic diversity in malignant melanomas. Am J Clin Pathol 1990; 93: 731–40.

    PubMed  CAS  Google Scholar 

  301. Banerjee SS, Harris M. Morphological and immunphenotypic variations in malignant melanoma. Histopathology 2000; 36: 387–402.

    Article  PubMed  CAS  Google Scholar 

  302. McGovern VJ, Shaw HM, Milton GW. Prognostic significance of a polypoid configuration in malignant melanoma. Histopathology 1983; 7: 663–72.

    Article  PubMed  CAS  Google Scholar 

  303. Giuliano AE, Cochran AJ, Morton DL. Melanoma from unknown primary site and amelanotic melanoma. Semin Oncol 1982; 9: 442–447.

    PubMed  CAS  Google Scholar 

  304. Peters MS, Su WPD. Balloon cell malignant melanoma. J Am Acad Dermatol 1985; 13: 351–4.

    Article  PubMed  CAS  Google Scholar 

  305. Kao GF, Helwig EB, Graham JH. Balloon cell malignant melanoma of the skin: a clinicopathologic study of 34 cases with histochemical, immunohistochemical, and ultra-structural observations. Cancer 1992; 69: 2942–52.

    Article  PubMed  CAS  Google Scholar 

  306. Novak MA, Fatteh SM, Campbell TE. Glycogen-rich malignant melanoma and glycogen-rich balloon cell melanoma. Arch Pathol Lab Med 1998: 122: 353–60.

    Google Scholar 

  307. Bhutta S, Mirra JM, Cocharan AJ. Myxoid malignant melanoma: a previously undescribed histologic pattern noted in metastatic lesions and a report of four cases. Am J Surg Pathol 1986; 10: 203–11.

    Article  Google Scholar 

  308. Sarode VR, Joshi K, Ravichandran P, Das R. Myxoid variant of primary cutaneous malignant melanoma. Histopathology 1992; 20: 186–7.

    Article  PubMed  CAS  Google Scholar 

  309. Prieto VG, Kanik A, Salob S, McNutt NS. Primary cutaneous myxoid melanoma: Immunohistologic clues to a difficult diagnosis. J Am Acad Dermatol 1994; 30: 335–9.

    Article  PubMed  CAS  Google Scholar 

  310. Clark WH Jr, Elder DE, Guerry D IV. Dysplastic nevi and malignant melanoma. In: Farmer ER, Hood AF, eds. Pathology of the Skin. Norwalk, Appleton and Lange, 1990: 684–756.

    Google Scholar 

  311. Crowson AN, Magro CM, Mihm MC Jr. Malignant melanoma with prominent pigment synthesis: “animal type” melanoma-a clinical and histological study of six cases with a consideration of other melanocytic neoplasms with prominent pigment synthesis. Hum Pathol 1999; 30: 543–50.

    Article  PubMed  CAS  Google Scholar 

  312. Macak J, Krc I, Elleder M, Lukas Z. Clear cell melanoma of the skin with regressive changes. Histopathology 1991; 18: 276–7.

    Article  PubMed  CAS  Google Scholar 

  313. Sheibani K, Battifora H. Signet-ring cell melanoma. Am J Surg Pathol 1988; 12: 28–34.

    Article  PubMed  CAS  Google Scholar 

  314. Al-Talib RK, Theaker JM. Signet-ring cell melanoma: light microscopic, immunohistochemical and ultrastructural features. Histopathology 1991; 18: 572–5.

    Article  PubMed  CAS  Google Scholar 

  315. LiVolsi VA, Brooks, JJ, Soslow R, et al. Signet cell melanocytic lesions. Mod Pathol 1992; 4: 515–20.

    Google Scholar 

  316. Borek BT, CmKee PH, Freeeman FA, et al. Primary malignant melanoma with rhaboid features: a histologic and immunocytochemical study of three cases. Am J Dermatopathol 1998: 20: 123–7.

    Article  PubMed  CAS  Google Scholar 

  317. Baron JA, Monzon F, Galaria N, Murphy GF. Angiomatoid melanoma: a novel pattern of differentiation in invasive periocular desmoplastic malignant melanoma. Hum Pathol 2000; 31: 1520–2.

    Article  PubMed  CAS  Google Scholar 

  318. Toda S, Heasley DD, Mihm MC. Osteogenic melanoma: stromal metaplasia in association with subungual melanoma. Histopathology 1997; 31: 293–5.

    PubMed  CAS  Google Scholar 

  319. Hoorweg JJ, Loftus BN, Hilgers FJM. Osteoid and bone formation in a nasal mucosal melanoma and its metastasis. Histopathology 1997; 31: 465–8.

    Article  PubMed  CAS  Google Scholar 

  320. Ross MI, Stern SJ. Mucosal melanoma. In: Balch CM, Houghton AN, Sober AJ, Soong S-J, eds. Cutaneous Melanoma. 3rd ed. St. Louis: Quality Medical, 1998; 195–206.

    Google Scholar 

  321. Piura B, Egan M, Lopes A, Monaghan JM. Malignant melanoma of the vulva: a clinicopathologic study of 18 cases. J Surg Oncol 1992; 50: 234–40.

    Article  PubMed  CAS  Google Scholar 

  322. Ragnarsson-Olding B, Johansson H, Rutquist L-E, Ringborg U. Malignat melanoma of the vulva and vagina. Trends in incidence, age distribution, and long-term survival among 245 consecutive cases in Sweden 1960–1984. Cancer 1993; 71: 1893–7.

    Article  PubMed  CAS  Google Scholar 

  323. Weinstock MA. Gynecology: malignant melanoma of the vulva and vagina in the United States: patterns of incidence and population-based estimates of survival. Am J Obstet Gynecol 1994; 171: 1225–30.

    PubMed  CAS  Google Scholar 

  324. Raeber G, Mempel V, Jackish C, et al. Malignant melanoma of the vulva: report of 89 patients. Cancer 1996; 78: 2353–8.

    Article  Google Scholar 

  325. Egan CA, Bradley RR, Logsdon VK, et al. Vulvar melanoma in childhood. Arch Dermatol 1997; 133: 345–8.

    Article  PubMed  CAS  Google Scholar 

  326. DeMatos P, Tyler D, Seigler H. Mucosal melanoma of the female genitalia: a clinicopathologic study of 43 cases at Duke University Medical Center. Surgery 1998; 124: 3 8–48.

    Google Scholar 

  327. Gorsky M, Epstein JB. Melanoma arising from the mucosal surfaces of the head and neck. Oral Surg Oral Med Oral Pathol 1998: 715–9.

    Google Scholar 

  328. Prasad ML, Patel S, Hoshaw-Woodard S, et al. Prognostic factors for malignant melanoma of the squamous mucosa of the head and neck. Am J Surg Pathol 2002; 26: 883–92.

    Article  PubMed  Google Scholar 

  329. Pandey M, Mathew A, Abraham EK, et al. Primary malignant melanoma of the mucous membranes. Eur J Surg Oncol 1998; 24: 303–7.

    Article  PubMed  CAS  Google Scholar 

  330. Larsson KBM, Shaw HM, Thompson JF, et al. Primary mucosal and glans penis melanomas: the Sydney melanoma unit experience. Aust NZ J Surg 1999; 69: 121–6.

    Article  CAS  Google Scholar 

  331. Oliva E, Quinn TR, Amin MB, et al. Primary malignant melanoma of the urethra. A clinicopathological analysis of 15 cases. Am J Sur Pathol 2000; 24 (6): 785–96.

    Article  CAS  Google Scholar 

  332. Pack GT, Miller TR. Metastatic melanomas with indeterminate primary site. J Am Med Assoc 1961; 176: 55–6.

    Article  CAS  Google Scholar 

  333. Smith JL Jr, Stehlin JS Jr. Spontaneous regression of primary malignant melanomas with regional metastases. Cancer 1965; 18: 1399–415.

    Article  PubMed  Google Scholar 

  334. McGovern VJ. Melanoma-growth patterns, multiplicity and regression. Paper presented at the International Cancer Conference, Sydney, 1972.

    Google Scholar 

  335. McGovern VJ, Shaw HM, Milton GW. Prognosis in patients with thin malignant melanoma: influence of regression. Histopathology 1983; 7: 673–80.

    Article  PubMed  CAS  Google Scholar 

  336. Blessing K, McLaren KM. Histological regression in primary cutaneous melanoma: Recognition, prevalence and significance. Histopathology 1992; 20: 315–22.

    Article  PubMed  CAS  Google Scholar 

  337. Tefany FJ, Barnetson RS, Halliday GM, et al. Immunocytochemical analysis of the cellular infiltrate in primary regressing and non-regressing malignant melanoma. J Invest Dermatol 1991; 97: 197–202.

    Article  PubMed  CAS  Google Scholar 

  338. Barnhill RL, Levy MA. Regressing thin cutaneous malignant melanomas (1.0 mm) are associated with angiogenesis. Am J Pathol 1993; 143: 99–104.

    PubMed  CAS  Google Scholar 

  339. Barr RJ, White GM, Kiao SY. Tumoral melanophagocytosis: a rare and confusing pattern of regressed melanoma. J Cutan Pathol 1990; 17: 287.

    Google Scholar 

  340. Barr RI. The many faces of completely regressed malignant melanoma. Pathology 1994; 2: 359–70.

    PubMed  CAS  Google Scholar 

  341. Sagebiel R. Pigmented lesion pathology: the specimen and its report. A personal and probably biased approach. Pathology 1994; 2: 281–98.

    PubMed  CAS  Google Scholar 

  342. Flax SH, Skelton HG, Smith KJ, Lupton GP. Nodular melanosis due to epithelial neoplasms. A finding not restricted to regressed melanomas. Am J Dermatopathol 1998: 20: 118–22.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Raymond L. Barnhill
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Dermatology, George Washington University Medical Center, Washington, DC, 20037, USA

    Raymond L. Barnhill MD (Chair, Professor of Dermatology and Pathology) (Chair, Professor of Dermatology and Pathology)

  2. Division of Dermatology and Department of Pathology, University of Washington School of Medicine, Seattle, WA, 98195, USA

    Michael Piepkorn MD, PhD (Clinical Professor) (Clinical Professor)

  3. Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, 10021, USA

    Klaus J. Busam MD (Associate Professor) (Associate Professor)

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Springer Science+Business Media New York

About this chapter

Cite this chapter

Barnhill, R.L. (2004). Malignant Melanoma. In: Barnhill, R.L., Piepkorn, M., Busam, K.J. (eds) Pathology of Melanocytic Nevi and Malignant Melanoma. Springer, New York, NY. https://doi.org/10.1007/978-0-387-21619-5_10

Download citation

  • DOI: https://doi.org/10.1007/978-0-387-21619-5_10

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4419-2327-1

  • Online ISBN: 978-0-387-21619-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation